Clinical trials

  • ASP2957 for X-linked myotubular myopathy
  • NIRAPARIB, ABIRATERONE ACETATE for Metastatic castration-sensitive prostate cancer (mCSPC)|HRR gene-mutated prostate cancer
  • 68GA-NOTA-ABSCINT-HER2 for Breast cancer | HER2-positive early breast cancer
  • TRABECTEDIN for Uterine leiomyosarcoma
  • CEMIPLIMAB for Melanoma|Advanced solid tumours|Clear-cell renal cell carcinoma (ccRCC)
  • Clinical trial in Spinal and Bulbar Muscular Atrophy
  • ATEZOLIZUMAB for Advanced malignancies | Locally advanced breast cancer | Ovarian cancer | Metastatic melanoma | Non-small cell lung cancer (stage IV) | Renal cell carcinoma | Squamous cell carcinoma of head and neck | Castration-resistant prostate cancer | Triple-negative breast cancer | Multiple myeloma | Metastatic colorectal cancer | Urothelial carcinoma
  • GALLIUM (68GA); PENTIXAFOR for Cardiac sarcoidosis
  • DEUCRAVACITINIB for Moderate to severe plaque psoriasis
  • PF-08065010 for Rheumatoid arthritis | Systemic lupus erythematosus
  • H-CYS(SS)-GLU-VAL-SER-GLN-LEU-LEU-LYS-GLY-ASP-ALA-CYS(SS)-OH for Ovarian cancer | Metastatic colorectal cancer | Metastatic pancreatic cancer | Metastatic cutaneous melanoma
  • GENTAMICIN for Infective Endocarditis